Pique Therapeutics is a biopharmaceutical company seeking to become the leader in the development of new therapeutic vaccines, focused initially on the treatment of cancer.

Pique is focused on the development of new therapies to treat non-small cell lung cancer, pancreatic cancer, colorectal cancer, and head & neck cancer. Our pipeline includes clinical and pre-clinical product candidates based on a novel therapeutic vaccine platform technology, which has been under development for over 10 years.